Targeting the epidermal growth factor receptor in metastatic colorectal cancer

K Ng, AX Zhu - Critical reviews in oncology/hematology, 2008 - Elsevier
Although significant advances have been made in the treatment of metastatic colorectal
cancer (CRC), prognosis remains poor, with a 5-year survival of less than 10%. Monoclonal …
被引用次数：72 相关文章

Targeting the epidermal growth factor receptor in metastatic colorectal cancer

K Ng, AX Zhu - Critical Reviews in Oncology/Hematology, 2008 - infona.pl
Although significant advances have been made in the treatment of metastatic colorectal
cancer (CRC), prognosis remains poor, with a 5-year survival of less than 10%. Monoclonal …

[引用][C] Targeting the epidermal growth factor receptor in metastatic colorectal cancer

K NG, AX ZHU - Critical reviews in oncology/hematology, 2008 - pascal-francis.inist.fr
Targeting the epidermal growth factor receptor in metastatic colorectal cancer CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Targeting the epidermal growth factor receptor in metastatic colorectal cancer

K Ng, AX Zhu - Critical reviews in oncology/hematology, 2008 - pubmed.ncbi.nlm.nih.gov
Although significant advances have been made in the treatment of metastatic colorectal
cancer (CRC), prognosis remains poor, with a 5-year survival of less than 10%. Monoclonal …

Targeting the epidermal growth factor receptor in metastatic colorectal cancer.

K Ng, AX Zhu - Critical Reviews in Oncology/hematology, 2007 - europepmc.org
Although significant advances have been made in the treatment of metastatic colorectal
cancer (CRC), prognosis remains poor, with a 5-year survival of less than 10%. Monoclonal …

[引用][C] Targeting the epidermal growth factor receptor in metastatic colorectal cancer

K NG, AX ZHU - Critical reviews in oncology/hematology, 2008 - Elsevier